Sarissa Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4M | Sell |
15,919,435
-470,565
| -3% | -$337K | 7.4% | 5 |
|
2025
Q1 | $24.1M | Hold |
16,390,000
| – | – | 15.57% | 4 |
|
2024
Q4 | $72.6M | Hold |
16,390,000
| – | – | 22.49% | 2 |
|
2024
Q3 | $67.5M | Hold |
16,390,000
| – | – | 16.78% | 2 |
|
2024
Q2 | $107M | Hold |
16,390,000
| – | – | 18.04% | 3 |
|
2024
Q1 | $143M | Hold |
16,390,000
| – | – | 24.97% | 1 |
|
2023
Q4 | $188M | Hold |
16,390,000
| – | – | 28.9% | 1 |
|
2023
Q3 | $158M | Hold |
16,390,000
| – | – | 21.26% | 3 |
|
2023
Q2 | $174M | Hold |
16,390,000
| – | – | 17.36% | 3 |
|
2023
Q1 | $172M | Hold |
16,390,000
| – | – | 22.05% | 3 |
|
2022
Q4 | $203M | Hold |
16,390,000
| – | – | 24.17% | 2 |
|
2022
Q3 | $170M | Hold |
16,390,000
| – | – | 19.19% | 3 |
|
2022
Q2 | $189M | Hold |
16,390,000
| – | – | 19.02% | 2 |
|
2022
Q1 | $206M | Hold |
16,390,000
| – | – | 19.49% | 2 |
|
2021
Q4 | $191M | Hold |
16,390,000
| – | – | 16.54% | 3 |
|
2021
Q3 | $214M | Hold |
16,390,000
| – | – | 16.8% | 2 |
|
2021
Q2 | $211M | Hold |
16,390,000
| – | – | 16.77% | 3 |
|
2021
Q1 | $183M | Buy |
16,390,000
+2,350,000
| +17% | +$26.3M | 17.56% | 1 |
|
2020
Q4 | $160M | Hold |
14,040,000
| – | – | 16.32% | 1 |
|
2020
Q3 | $126M | Hold |
14,040,000
| – | – | 14.87% | 4 |
|
2020
Q2 | $145M | Buy |
14,040,000
+515,000
| +4% | +$5.31M | 16.12% | 3 |
|
2020
Q1 | $136M | Buy |
13,525,000
+3,218,000
| +31% | +$32.5M | 17.41% | 2 |
|
2019
Q4 | $137M | Buy |
10,307,000
+204,000
| +2% | +$2.72M | 11.39% | 3 |
|
2019
Q3 | $86.7M | Buy |
10,103,000
+385,000
| +4% | +$3.31M | 10.87% | 4 |
|
2019
Q2 | $106M | Buy |
9,718,000
+712,613
| +8% | +$7.8M | 13.25% | 4 |
|
2019
Q1 | $102M | Buy |
9,005,387
+1,540,141
| +21% | +$17.5M | 15.36% | 3 |
|
2018
Q4 | $64.8M | Buy |
7,465,246
+3,444,929
| +86% | +$29.9M | 14.35% | 4 |
|
2018
Q3 | $62.2M | Hold |
4,020,317
| – | – | 13.71% | 4 |
|
2018
Q2 | $64.4M | Hold |
4,020,317
| – | – | 12.91% | 3 |
|
2018
Q1 | $52M | Buy |
4,020,317
+2,050,217
| +104% | +$26.5M | 12.02% | 5 |
|
2017
Q4 | $24.7M | Buy |
+1,970,100
| New | +$24.7M | 6.33% | 6 |
|